Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 29;10(7):1503.
doi: 10.3390/foods10071503.

Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity

Affiliations

Potential In Vitro Inhibition of Selected Plant Extracts against SARS-CoV-2 Chymotripsin-Like Protease (3CLPro) Activity

Carla Guijarro-Real et al. Foods. .

Abstract

Antiviral treatments inhibiting Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication may represent a strategy complementary to vaccination to fight the ongoing Coronavirus disease 19 (COVID-19) pandemic. Molecules or extracts inhibiting the SARS-CoV-2 chymotripsin-like protease (3CLPro) could contribute to reducing or suppressing SARS-CoV-2 replication. Using a targeted approach, we identified 17 plant products that are included in current and traditional cuisines as promising inhibitors of SARS-CoV-2 3CLPro activity. Methanolic extracts were evaluated in vitro for inhibition of SARS-CoV-2 3CLPro activity using a quenched fluorescence resonance energy transfer (FRET) assay. Extracts from turmeric (Curcuma longa) rhizomes, mustard (Brassica nigra) seeds, and wall rocket (Diplotaxis erucoides subsp. erucoides) at 500 µg mL-1 displayed significant inhibition of the 3CLPro activity, resulting in residual protease activities of 0.0%, 9.4%, and 14.9%, respectively. Using different extract concentrations, an IC50 value of 15.74 µg mL-1 was calculated for turmeric extract. Commercial curcumin inhibited the 3CLPro activity, but did not fully account for the inhibitory effect of turmeric rhizomes extracts, suggesting that other components of the turmeric extract must also play a main role in inhibiting the 3CLPro activity. Sinigrin, a major glucosinolate present in mustard seeds and wall rocket, did not have relevant 3CLPro inhibitory activity; however, its hydrolysis product allyl isothiocyanate had an IC50 value of 41.43 µg mL-1. The current study identifies plant extracts and molecules that can be of interest in the search for treatments against COVID-19, acting as a basis for future chemical, in vivo, and clinical trials.

Keywords: COVID-19; FRET assay; SARS-CoV-2 3CLPro; allyl isothiocyanate; curcumin; mustard seeds; natural compounds; plant extracts; turmeric; wall rocket.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Mean values and standard errors (SEs) for the residual activity of SARS-CoV-2 3CLPro in the presence of the fifteen plant-based extracts at a concentration of 500 µg mL−1 and the inhibitor control GC376 at a concentration of 50 µM (n = 4). Extracts included were obtained from citrus fruit peels (blue), seasoning and aromatic herbs (green), bulbs and rhizomes (purple; includes turmeric), a succulent plant (red), and cruciferous herbs and condiments (yellow). Both the turmeric extract and the inhibitor GC376 produced a complete inhibition of the 3CLPro. Different letters indicate significant differences in the 3CLPro residual activity according to a Student–Newman–Keuls test at p < 0.05.
Figure 2
Figure 2
(a) Dose–response curve for the methanolic extract of turmeric powder. Each point represents the average value and SE for the residual activity of the 3CLPro (%) at extract concentrations between 5.0 and 500 µg mL−1 (n = 4). The 100% of residual activity considers the activity of the 3CLPro when no inhibitor is added. (b) Mean residual activity and SE of 3CLPro (%) determined after the co-incubation with five different concentrations of commercial curcumin (2.5–75 µg mL−1) (n = 4). Different letters indicate significant differences in the 3CLPro residual activity according to a Student–Newman–Keuls test at p < 0.05.
Figure 3
Figure 3
(a) Dose–response curve for the methanolic extracts of mustard seeds (blue circles) and wall rocket leaves (orange squares). Each point represents the average value and SE for the residual activity of the 3CLPro (%) at extract concentrations between 5.0 and 500 µg mL−1 (n = 4). The 100% of residual activity is the activity of the 3CLPro when no inhibitor is added. (b) Mean residual activity and SE of 3CLPro (%) determined after the co-incubation with 5.0–500 µg mL−1 of sinigrin (grey) and allyl isothiocyanate (black) standards (n = 4). Different letters indicate significant differences in the 3CLPro residual activity for sinigrin or allyl isothiocyanate treatments according to two separate Student–Newman–Keuls tests at p < 0.05.

Similar articles

Cited by

References

    1. Salian V.S., Wright J.A., Vedell P.T., Nair S., Li C., Kandimalla M., Tang X., Porquera E.M.C., Kalari K.R., Kandimalla K.K. COVID-19 transmission, current treatment, and future therapeutic strategies. Mol. Pharm. 2021;18:754–771. doi: 10.1021/acs.molpharmaceut.0c00608. - DOI - PubMed
    1. World Health Organization Coronavirus Disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update. Coronavirus Disease (COVID-19) [(accessed on 8 April 2021)]; Available online: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio....
    1. Astuti I., Ysrafil Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:407–412. doi: 10.1016/j.dsx.2020.04.020. - DOI - PMC - PubMed
    1. Islam M.R., Hoque M.N., Rahman M.S., Ul Alam A.S.M.R., Akther M., Puspo J.A., Akter S., Sultana M., Crandall K.A., Hossain M.A. Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Sci. Rep. 2020;10:14004. doi: 10.1038/s41598-020-70812-6. - DOI - PMC - PubMed
    1. Laamarti M., Alouane T., Kartti S., Chemao-Elfihri M.W., Hakmi M., Essabbar A., Laamarti M., Hlali H., Bendani H., Boumajdi N., et al. Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geodistribution and a rich genetic variations of hotspots mutations. PLoS ONE. 2020;15:e0240345. doi: 10.1371/journal.pone.0240345. - DOI - PMC - PubMed